PathMaker Neurosystems is opening up a new era of non-invasive treatment of serious neurological disorders based on groundbreaking advances in Multi-site Neuromodulation that enables the safe and non-invasive treatment of patients with Spasticity and ALS. Our proprietary technology is built upon the pioneering work of Prof. Zaghloul Ahmed (CUNY) and our scientific advisors. With offices in Boston, New York and Paris, we are rapidly moving forward our clinical-stage programs with a veteran team of medical device executives.